Canada markets close in 5 hours 36 minutes

Emerald Health Therapeutics, Inc. (EMHTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.20000.0000 (0.00%)
As of 10:07AM EDT. Market open.
Currency in USD

Valuation Measures

Market Cap (intraday) 540.39M
Enterprise Value 3-173.82k
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)3.10
Price/Book (mrq)0.50
Enterprise Value/Revenue 3-0.01
Enterprise Value/EBITDA 70.01

Trading Information

Stock Price History

Beta (5Y Monthly) 1.07
52-Week Change 381.82%
S&P500 52-Week Change 349.17%
52 Week High 30.4660
52 Week Low 30.1050
50-Day Moving Average 30.2291
200-Day Moving Average 30.1980

Share Statistics

Avg Vol (3 month) 3703.75k
Avg Vol (10 day) 3171.31k
Shares Outstanding 5205.03M
Implied Shares Outstanding 6N/A
Float 166.8M
% Held by Insiders 119.48%
% Held by Institutions 10.94%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Sep. 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)-242.99%

Management Effectiveness

Return on Assets (ttm)-9.97%
Return on Equity (ttm)-91.66%

Income Statement

Revenue (ttm)13.02M
Revenue Per Share (ttm)0.07
Quarterly Revenue Growth (yoy)-63.70%
Gross Profit (ttm)-10.79M
EBITDA -27.46M
Net Income Avi to Common (ttm)-125.26M
Diluted EPS (ttm)-0.5560
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)68.67M
Total Cash Per Share (mrq)0.33
Total Debt (mrq)28.42M
Total Debt/Equity (mrq)35.45
Current Ratio (mrq)2.97
Book Value Per Share (mrq)0.40

Cash Flow Statement

Operating Cash Flow (ttm)-5.13M
Levered Free Cash Flow (ttm)-1.95M